REMYLIN (Alpha lipoic acid 100mg + Folic acid 1.5mg + Mecobalamin 1500mcg + Pyridoxine3mg)
-15%

REMYLIN (Alpha lipoic acid 100mg + Folic acid 1.5mg + Mecobalamin 1500mcg + Pyridoxine3mg)

Original price was: ₹195.30.Current price is: ₹166.64.

REMYLIN (Alpha lipoic acid 100mg + Folic acid 1.5mg + Mecobalamin 1500mcg + Pyridoxine3mg)

Original price was: ₹195.30.Current price is: ₹166.64.

Add to cart
Buy Now
Category: Tag:

Remylin Tablet is a dietary supplement designed to deliver key nutrients that play a crucial role in promoting overall health and well-being. It contains mecobalamin, alpha lipoic acid, pyridoxine, and folic acid, which contribute to various essential physiological processes in the body. Mecobalamin, a form of vitamin B12, is vital for maintaining healthy nerve cells and is involved in the formation of red blood cells. Alpha lipoic acid serves as an antioxidant, helping to protect cells from damage and supporting metabolic processes. Pyridoxine, or vitamin B6, is necessary for amino acid metabolism and the synthesis of neurotransmitters, which are important for brain function. Folic acid, a B vitamin, is critical for DNA synthesis and repair, making it an important nutrient in cellular function. Together, these components foster enhanced immunity and assist in the synthesis of both brain and nerve tissues. Regular intake of Remylin may promote improved health outcomes related to nerve function, blood health, and overall metabolic activities within the body, making it a valuable addition to a balanced health regimen. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.

Reviews

There are no reviews yet.

Be the first to review “REMYLIN (Alpha lipoic acid 100mg + Folic acid 1.5mg + Mecobalamin 1500mcg + Pyridoxine3mg)”

Your email address will not be published. Required fields are marked *

Top